Press Releases

Upcoming Events

J.P. Morgan Health Care Investor Conference 2019
Monday, January 07 - Thursday, January 10

San Francisco, CA

American Chemical Society National Meeting 2019
Sunday, March 31 - Thursday, April 04

Orlando, FL

ECCMID 2019
Saturday, April 13 - Tuesday, April 16

Amsterdam, The Netherlands

> See all Events
July 27, 2017

The funding will be used to support discovery and preclinical development of a new class of antibiotic that circumvents beta-lactam antibiotic resistance, but with the same safe and effective mechanism of action of beta-lactams.

July 25, 2017

Proceeds will be used to advance the company’s portfolio, including lead product candidate VNRX-5133 for multi-drug resistant (MDR) gram-negative infections.

Archive: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010